Panayiotis Savvides

Hematology | Oncology

101 Civic Center Ln
Lake Havasu City, AZ 86403

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305.

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 22, 2023

Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center.

Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center.

Journal: Oral oncology

Published: May 08, 2023

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).

Journal: Oral oncology

Published: August 04, 2022

Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.

Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.

Journal: Clinical lung cancer

Published: May 02, 2022

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 11, 2022

Role of Prophylactic Cranial Irradiation in Extensive-Stage Small Cell Lung Cancer.

Role of Prophylactic Cranial Irradiation in Extensive-Stage Small Cell Lung Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: July 20, 2021

The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer.

The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer.

Journal: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

Published: July 14, 2021

Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.

Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 17, 2019

A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

Journal: Investigational new drugs

Published: June 04, 2018

Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma.

Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma.

Journal: Head & neck

Published: December 19, 2014

Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design.

Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design.

Journal: Head & neck

Published: June 04, 2014

Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid.

Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid.

Journal: Thyroid : official journal of the American Thyroid Association

Published: November 02, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026